BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 26159270)

  • 1. Challenges and Management of Liver Cirrhosis: Pathophysiology of Renal Dysfunction in Cirrhosis.
    Solà E; Ginès P
    Dig Dis; 2015; 33(4):534-8. PubMed ID: 26159270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LEFT ventricular function assessed by echocardiography in cirrhosis: relationship to systemic hemodynamics and renal dysfunction.
    Nazar A; Guevara M; Sitges M; Terra C; Solà E; Guigou C; Arroyo V; Ginès P
    J Hepatol; 2013 Jan; 58(1):51-7. PubMed ID: 22989573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis of Hepatorenal Syndrome: Implications for Therapy.
    Durand F; Graupera I; Ginès P; Olson JC; Nadim MK
    Am J Kidney Dis; 2016 Feb; 67(2):318-28. PubMed ID: 26500178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathophysiology of Hepatorenal Syndrome.
    Velez JCQ; Latt N; Rodby RA
    Adv Kidney Dis Health; 2024 Mar; 31(2):87-99. PubMed ID: 38649221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complications of cirrhosis. II. Renal and circulatory dysfunction. Lights and shadows in an important clinical problem.
    Arroyo V; Jiménez W
    J Hepatol; 2000; 32(1 Suppl):157-70. PubMed ID: 10728802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review article: pathogenesis and pathophysiology of hepatorenal syndrome--is there scope for prevention?
    Møller S; Henriksen JH
    Aliment Pharmacol Ther; 2004 Sep; 20 Suppl 3():31-41; discussion 42-3. PubMed ID: 15335398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kidney injury in cirrhosis: pathophysiological and therapeutic aspects of hepatorenal syndromes.
    Møller S; Krag A; Bendtsen F
    Liver Int; 2014 Sep; 34(8):1153-63. PubMed ID: 24673771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatorenal syndrome.
    Gattoni A; Marotta F; Vangieri B; Pisani G; Cristiano F
    Clin Ter; 2004 Sep; 155(9):375-89. PubMed ID: 15700631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular adsorbent recirculating system is ineffective in the management of type 1 hepatorenal syndrome in patients with cirrhosis with ascites who have failed vasoconstrictor treatment.
    Wong F; Raina N; Richardson R
    Gut; 2010 Mar; 59(3):381-6. PubMed ID: 19710033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Renal damage in liver cirrhosis: pathophysiology and management].
    Yamamoto T; Hishida A
    Nihon Rinsho; 1994 Jan; 52(1):159-64. PubMed ID: 8114286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hepatorenal syndrome].
    Mijac D; Kezić A; Stojimirović B
    Srp Arh Celok Lek; 2007; 135(1-2):98-104. PubMed ID: 17503577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenetic factors and clinical elements in ascites and hepatorenal syndrome during liver cirrhosis.
    Gentilini P; Laffi G; La Villa G; Raggi VC
    Ann Ital Med Int; 1999; 14(4):264-84. PubMed ID: 10638019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluid retention in cirrhosis: pathophysiology and management.
    Kashani A; Landaverde C; Medici V; Rossaro L
    QJM; 2008 Feb; 101(2):71-85. PubMed ID: 18184668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Terlipressin in hepatorenal syndrome: Evidence for present indications.
    Rajekar H; Chawla Y
    J Gastroenterol Hepatol; 2011 Jan; 26 Suppl 1():109-14. PubMed ID: 21199521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New Developments in Hepatorenal Syndrome.
    Mindikoglu AL; Pappas SC
    Clin Gastroenterol Hepatol; 2018 Feb; 16(2):162-177.e1. PubMed ID: 28602971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatorenal syndrome.
    Bataller R; Arroyo V; Ginès P; Sort P
    Forum (Genova); 1998; 8(1):62-81. PubMed ID: 9565447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatorenal syndrome.
    Kramer L; Hörl WH
    Semin Nephrol; 2002 Jul; 22(4):290-301. PubMed ID: 12118394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis of ascites in cirrhosis and portal hypertension.
    Heneghan MA; Harrison PM
    Med Sci Monit; 2000; 6(4):807-16. PubMed ID: 11208415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hepatorenal syndrome].
    Pillebout E
    Nephrol Ther; 2014 Feb; 10(1):61-8. PubMed ID: 24388293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatorenal syndrome: a severe, but treatable, cause of kidney failure in cirrhosis.
    Fagundes C; Ginès P
    Am J Kidney Dis; 2012 Jun; 59(6):874-85. PubMed ID: 22480795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.